Why The Drive For Medical Transition Should Be Re-Psychopathologized (#42)
9 October 2025
Global
Hosts Stella O'Malley and Mia Hughes set out the reasoning behind Genspect's 2025 campaign to restore psychiatric safeguards around the drive for medical gender transition. Drawing on fifteen years of diagnostic history — from WPATH's 2010 statement to the WHO's ICD-11 reclassification — they argue that compulsive pursuit of irreversible interventions in healthy bodies is a clinical concern requiring mental health evaluation. The episode has direct relevance for Irish practice, where HSE services operate under the same internationally-derived guidelines that progressively removed those safeguards.
In October 2025, Genspect launched a formal campaign calling for what it terms the re-psychopathologization of the drive toward medical gender transition. In this episode, Stella O'Malley and Mia Hughes walk through the reasoning behind that campaign, the sequence of institutional decisions that dismantled psychiatric safeguards in gender medicine over the previous fifteen years, and why restoring them would, in their view, represent a more compassionate clinical response to young people in distress. The diagnostic history they describe begins in 2010, when WPATH issued a statement declaring gender-variant identities natural and healthy and calling for the removal of the pathology designation. Three years later, the DSM-5 replaced Gender Identity Disorder with Gender Dysphoria, retaining distress as the clinical concern while treating the identity itself as benign. Then, in 2018, the WHO's ICD-11 went further still, moving gender incongruence out of the mental health chapter entirely into one covering conditions related to sexual health. Ireland's Health Service Executive, in line with most European public health systems, operates within ICD frameworks. Each reclassification reduced the level of psychological evaluation that clinicians were expected to carry out before a young person was placed on a medical pathway. The central distinction O'Malley and Hughes draw is between identity and behaviour. A young person exploring a transgender identity, or questioning their gender, is not, they argue, exhibiting anything that warrants a clinical label. What does require careful mental health assessment, in their view, is the compulsive, escalating drive to undergo irreversible surgery and lifelong hormonal medication — interventions that permanently alter a healthy body and carry serious long-term consequences. It is that drive, not the identity, that they argue medicine effectively stopped scrutinising when it adopted the de-pathologized framework. This framing matters for how Irish gender services are constituted and governed. The HSE's National Gender Service and the child and adolescent pathways that have developed alongside it draw on international guidelines, including WPATH's Standards of Care, which were themselves shaped by the de-psychopathologization logic the episode traces. While the Cass Review in England prompted a formal NHS reassessment of those guidelines and led to measurable changes in clinical protocol, no equivalent independent review has been mandated in Ireland. The influence of WPATH's framework on Irish clinical practice therefore remains largely unexamined at a national level. Hughes approaches the subject as a researcher and examines how classification decisions are made and how their downstream effects propagate through clinical systems. One of the concerns she raises is that removing the pathology designation was presented publicly as an act of compassion toward transgender people, while its practical consequence was to reduce the mental health support available to the most distressed patients — precisely those who most needed sustained therapeutic engagement rather than rapid medical intervention. The episode situates Genspect's campaign within a wider evidence landscape. Systematic reviews in Sweden, Finland, Denmark and England have each reached cautious or critical conclusions about the evidence base for paediatric medical transition, and the question of whether the diagnostic frameworks underpinning those pathways need reconsidering is no longer a position held only at the margins. Genspect's campaign gives that challenge a formal institutional shape, and this episode provides the clinical and ethical reasoning behind it.
